Effect of COVID-19 pandemic on ART access and timely initiation in people living with HIV in 31 countries: a regression discontinuity design study
Jihane Ben Farhat, Eugène Messou, Rohidas Borse, Diana Varela Bustillo, Metsekae Madimabe, Denis Nash, Helen Byakwaga, N Sarita Shah, Oliver Ezechi, Sanjay Pujari, Valdiléa G Veloso, Michael Hobbins, Gad Murenzi, Denna Mkwashapi, Brenna Hogan, Jun Yong Choi, Albert Minga

TL;DR
The study found that the COVID-19 pandemic had mixed effects on HIV treatment access, with some countries maintaining stable ART initiations while others saw declines.
Contribution
This study uses a regression discontinuity design to assess the impact of the pandemic on ART access and timely initiation across 31 countries.
Findings
ART initiation numbers remained stable in 25 out of 31 countries during the pandemic.
Six countries experienced significant decreases in ART initiations, including South Africa and Malawi.
The proportion of timely ART initiations increased in Kenya and Mozambique during the pandemic.
Abstract
The COVID-19 pandemic threatened global HIV Test and Treat Efforts. We assessed whether it affected (1) the number of antiretroviral therapy (ART) initiations and (2) the proportion of timely ART initiations in people living with HIV (PLWH) globally. Quasi-experimental, regression discontinuity design using routinely collected data from HIV clinics. 360 HIV care clinics across primary and secondary levels of care, participating in the International epidemiology Databases to Evaluate AIDS consortium, in 31 countries in Asia, Africa and the Americas. 177 391 PLWH (≥18 years old) who initiated ART 2 years before and 1 year after the onset of the COVID-19 pandemic in their country. The primary outcome was the number of ART initiations per week; the secondary outcome was the proportion of timely ART initiations (ie, ART initiated within 7 days of enrolment). We assessed changes in these…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV/AIDS Research and Interventions · HIV, Drug Use, Sexual Risk · Adolescent Sexual and Reproductive Health
